Catalyst
Slingshot members are tracking this event:
Concert Expects to Launch Phase 2 Study of CTP-656 for Cystic Fibrosis in H2 of 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CNCE |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 21, 2016
Occurred Source:
http://ir.concertpharma.com/releasedetail.cfm?ReleaseID=1005136
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ctp-656, Cystic Fibrosis, Gating Mutations, Phase 2 Study
